sandoz-21-009 has been researched along with Muscle Contraction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosohata, Y; Karakisawa, Y; Maruyama, K; Nagatomo, T; Sasaki, K; Suzuki, M; Tsuchihashi, H | 1 |
| Akashi, H; Hosohata, Y; Kinami, J; Nagatomo, T; Sakuma, N; Tsuchihashi, H | 1 |
2 other study(ies) available for sandoz-21-009 and Muscle Contraction
| Article | Year |
|---|---|
Alpha-1 and beta-adrenergic receptor blocking potencies of bopindolol and its two metabolites (18-502 and 20-785) as assessed by radioligand binding assay methods.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cattle; Dogs; Heart; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Myocardium; Phenylephrine; Pindolol; Radioligand Assay; Rats; Spleen; Trachea | 1995 |
Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.
Topics: Adrenergic beta-Antagonists; Animals; Binding, Competitive; Brain; Guinea Pigs; Heart Rate; In Vitro Techniques; Iodocyanopindolol; Kinetics; Muscle Contraction; Myocardium; Pindolol; Propanolamines; Radioligand Assay; Rats; Receptors, Adrenergic, beta; Trachea | 1991 |